Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3465112 | PMC |
http://dx.doi.org/10.4103/2230-973X.76720 | DOI Listing |
Cells
March 2024
Adelaide Medical School, University of Adelaide, Adelaide, SA 5005, Australia.
Purpose Of This Review: Manipulating or re-engineering the damaged human spinal cord to achieve neuro-recovery is one of the foremost challenges of modern science. Addressing the restricted permission of neural cells and topographically organised neural tissue for self-renewal and spontaneous regeneration, respectively, is not straightforward, as exemplified by rare instances of translational success. This review assembles an understanding of advances in nanomedicine for spinal cord injury (SCI) and related clinical indications of relevance to attempts to design, engineer, and target nanotechnologies to multiple molecular networks.
View Article and Find Full Text PDFMol Pharm
January 2017
Institut National de la Recherche Scientifique-Institut Armand Frappier , Laval, Québec H7V 1B7, Canada.
One major challenge in the field of nanotherapeutics is to increase the selective delivery of cargo to targeted cells. Using polylactic-co-glycolic acid (PLGA), we recently highlighted the importance of polymer composition in the biological fate of the nanodrug delivery systems. However, the route of internalization of polymeric nanoparticles (NPs) is another key component to consider in the elaboration of modern and targeted devices.
View Article and Find Full Text PDFInt J Pharm Investig
January 2011
INRS-Institut Armand-Frappier, 531, boul. des Prairies, H7V 1B7 Laval, Québec, Canada.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!